IP Library Granted Patent US 9,447,410
Granted Patent B2
US 9,447,410 · App. 14/249,904 · Granted Sep 20, 2016

T cell receptor display

Inventors: Bent Karsten Jakobsen (Oxfordshire, GB); Peter Eamon Molloy (Oxfordshire, GB); Yi Li (Oxfordshire, GB); Jonathan Michael Boulter (Blackwood, GB)
Assignees: ADAPTIMMUNE LIMITED; IMMUNOCORE LIMITED
C12N15/1037C07K14/7051C12N7/00C12N15/1041C12N15/1058C40B40/02A61K38/00C12N2795/18121C12N2795/18143C40B40/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,447,410
App. No.
14/249,904
Granted
Sep 20, 2016
Kind
B2
Abstract

A proteinaceous particle, for example a bacteriophage, ribosome or cell, displaying on its surface a T-cell receptor (TCR). The displayed TCR is preferably a heterodimer having a non-native disulfide bond between constant domain residues. Such display particles may be used for the creation of diverse TCR libraries for the identification of high affinity TCRs. Several high affinities are disclosed.

Claims (19)

1. A phage particle displaying on its surface a dimeric T-cell receptor (dTCR) polypeptide pair, wherein the dTCR polypeptide pair comprises

a first polypeptide wherein a TCR α or δ chain variable domain sequence is fused to N

terminus of a TCR αchain constant domain extracellular sequence, and

a second polypeptide wherein a TCR β or γ chain variable domain sequence is fused to N

terminus of a TCR β chain constant domain extracellular sequence,

wherein the first and second polypeptides are linked by a disulfide bond which corresponds to a native inter-chain disulfide bond present in native dimeric αβ TCRs.

2. The phage particle of claim 1 wherein the phage particle is a filamentous phage particle.

3. The phage particle of claim 1 or claim 2 wherein C-terminus of one member of the dTCR polypeptide pair is linked by a peptide bond to a surface exposed residue of the phage particle.

4. A diverse library of phage particles as claimed in claim 1 .

5. The diverse library of claim 4 wherein diversity resides in the variable domain(s) of the dTCR polypeptide pair.

6. A method for identifying TCRs with a specific characteristic comprising subjecting the diverse library of phage particles displaying TCRs of claim 4 or claim 5 to

a selection process comprising selecting for the characteristic, and isolating phage particles which display a TCR having the characteristic, and optionally to an amplification process to multiply the isolated particles and/or

a screening process comprising measuring for the characteristic, identifying phage particles displaying a TCR with the characteristic and isolating the phage particles, and

optionally to an amplification process to multiply the isolated particles.

7. The method of claim 6 wherein the specific characteristic is increased affinity for a TCR ligand.

8. A diverse library of phage particles as claimed in claim 2 .

9. The diverse library of claim 8 wherein diversity resides in the variable domain(s) of the dTCR polypeptide pair.

10. A diverse library of phage particles as claimed in claim 3 .

11. The diverse library of claim 10 wherein diversity resides in the variable domain(s) of the dTCR polypeptide pair.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2022
From: OXFORD FINANCE LUXEMBOURG S.À R.L
To: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
Reel/Frame 061916/0493 →
SECURITY INTEREST Recorded Nov 6, 2020
From: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
To: OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
Reel/Frame 054344/0218 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEES PREVIOUSLY RECORDED AT REEL: 032662 FRAME: 0815. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 10, 2014
From: IMMUNOCORE LIMITED
To: IMMUNOCORE LIMITED; ADAPTIMMUNE LIMITED
Reel/Frame 033109/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2014
From: IMMUNOCORE LIMITED
To: ADAPTIMMUNE LIMITED
Reel/Frame 032662/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2014
From: MEDIGENE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 032662/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2014
From: JAKOBSEN, BENT KARSTEN; ANDERSEN, TORBEN BENT; MOLLOY, PETER EAMON; LI, YI; BOULTER, JONATHAN MICHAEL
To: AVIDEX LIMITED
Reel/Frame 032658/0612 →
CHANGE OF NAME Recorded Apr 11, 2014
From: AVIDEX LIMITED
To: MEDIGENE LIMITED
Reel/Frame 032658/0776 →
Priority Claims (5)
GB 0226227.7 · Nov 9, 2002 · national
GB 0301814.0 · Jan 25, 2003 · national
GB 0304067.2 · Feb 22, 2003 · national
GB 0311397.4 · May 16, 2003 · national
GB 0316356.5 · Jul 11, 2003 · national
Continuity (4)
Division 12603255 · Oct 21, 2009
Division 10532879
Provisional Application 60463046 · Apr 16, 2003
Related Publication 20140349855A1 · Nov 27, 2014